Compound ID | 803
Class: Oxazolidinone
| Spectrum of activity: | Gram-negative |
| Details of activity: | Protein synthesis inhibitors; improved potency against Gram positive bacteria such as S. aureus and S. pneumoniae strains |
| Description: | Renslo AR, Gao H, Blais J, et al. Structure-activity studies of the C-ring nitrogen substituent in a new class of azabicyclo[3.1.0]hexylphenyl oxazolidinone analogs. 45th-Intersci-Conf-Antimicrob-Agents-Chemother 2005;202 |
| Institute where first reported: | Vicuron Pharmaceuticals (Durata Pharmaceuticals, USA) |
| Year first mentioned: | 2005 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |